Company Disclosures › Sub-category

Restructuring

1 article

Aurobindo Pharma Transfers Domestic Business to Subsidiary

Aurobindo Pharma's board approved the slump sale of its domestic branded generics business to its wholly-owned subsidiary, Auropharm Limited, for INR 143.21 crore. The transaction, executed on April 6